Catalyst Wire Dossier Catalyst Wire Dossier

LATISSE

BIMATOPROST · Allergan, Inc.
Drug timelines are a Plus or Pro feature.

16 regulatory and trial events tracked for LATISSE, covering 2008-12-24 to 2021-08-26. Get the full timeline:

Most recent: FDA Approved: LATISSE — Supplemental Application (Allergan, Inc.)

See pricing